Dublin, May 18, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/nq...l_counting ) has announced the addition of the "Cell Counting Market by Product, End User - Global Forecast to 2020" report to their offering. The global cell counting market is expected to reach $8.6 Billion by the end of 2020 and is poised to grow at a CAGR of 6.5% to 7.0% during the forecast period (2015 to 2020)
This market is mainly driven by the rising incidences of cancer and infectious disease, increasing R&D expenditure and healthcare spending, and growing stem cell and cancer research,. However, high cost of cell counting instruments such as flow cytometers and multi-mode readers is inhibiting the growth of this market to a certain extent. The global market is classified on the basis of products and end users. On the basis of products, the market is categorized into instruments and consumables. The instruments segment is further segmented into cell counters, flow cytometers, hematology analyzers, and spectrophotometers. The cell counters segment is further divided into automated cell counters and manual cell counters. The spectrophotometers segment is divided into single-mode readers and multi-mode readers.
The consumables segment is divided into assay kits, reagents, microplates, accessories, and others. On the basis of end users, the market is divided into hospitals and diagnostic laboratories, research institutions, biotechnology and pharmaceutical companies, and other end users. On the basis of regions, this market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which is further analyzed at country levels. The research report discusses the key market drivers, restraints, challenges, and opportunities in the global market and its submarkets. In 2014, the spectrophotometers segment accounted for the largest share of the market. This market is primarily driven by the recent technological advancements in data visualization and analysis software, corporate and government funding and investments in prompting cell-based research, and growing out-of-pocket healthcare spending. North America represented the largest regional market in 2014, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the fastest-growing market for the cell counting instruments and consumables, primarily due to the increasing R&D and healthcare expenditure and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are further driving the market in these regions. Major players in the global cell counting market are Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.). For more information visit http://www.researchandmarkets.com/research/nq...l_counting
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology